quetiapine-fumarate has been researched along with Inappropriate-ADH-Syndrome* in 4 studies
4 other study(ies) available for quetiapine-fumarate and Inappropriate-ADH-Syndrome
| Article | Year |
|---|---|
Hyponatremia secondary to SIADH in a schizophrenic patient treated with Quetiapine.
Topics: Antipsychotic Agents; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Quetiapine Fumarate; Respiration, Artificial; Saline Solution, Hypertonic; Schizophrenia | 2018 |
Syndrome of Inappropriate Antidiuretic Hormone in a Patient Receiving High-Dose Haloperidol and Quetiapine Therapy.
Topics: Adult; Haloperidol; Humans; Inappropriate ADH Syndrome; Male; Psychomotor Agitation; Quetiapine Fumarate | 2016 |
A challenging case of syndrome of inappropriate secretion of antidiuretic hormone in an elderly patient secondary to quetiapine.
Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is an uncommon complication of treatment with centrally acting drugs including selective serotonin reuptake inhibitors (SSRIs) and antipsychotic medications. Antipsychotics are commonly used for the treatment of behavioral and psychiatric symptoms in elderly patients with dementia, and the use of those agents is increasing. Here, we report an elderly man who developed hyponatremia after treatment with medications for depression and agitation. Topics: Aged; Antipsychotic Agents; Depressive Disorder; Dibenzothiazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Quetiapine Fumarate | 2007 |
[The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine].
A 45-year-old man with paranoid schizophrenia repeatedly developed hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), both after treatment with haloperidol and after taking quetiapine. This side effect did not occur subsequently during clozapine treatment. SIADH has been described in connection with almost all psychotropic drugs. Since the risk of developing SIADH is increased with increasing age, comorbid somatic disorders and polypharmacy, and the mean age of the psychiatric patient will further increase in the years to come, the physician should be alert to the risk factors and the clinical symptoms of disturbances in water balance; moreover, the proper differential diagnostic deliberations should be made. In case of increased risk, it is recommended to monitor the serum sodium during the first 2-4 weeks of pharmacotherapy. Topics: Age Factors; Antipsychotic Agents; Dibenzothiazepines; Haloperidol; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Quetiapine Fumarate; Risk Factors; Schizophrenia, Paranoid | 2006 |